CN111329053A - 一种养生莓耳枣薏瑪粉 - Google Patents
一种养生莓耳枣薏瑪粉 Download PDFInfo
- Publication number
- CN111329053A CN111329053A CN201911246400.XA CN201911246400A CN111329053A CN 111329053 A CN111329053 A CN 111329053A CN 201911246400 A CN201911246400 A CN 201911246400A CN 111329053 A CN111329053 A CN 111329053A
- Authority
- CN
- China
- Prior art keywords
- health
- coix seed
- powder
- preserving
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 53
- 244000077995 Coix lacryma jobi Species 0.000 title claims abstract description 34
- 235000016623 Fragaria vesca Nutrition 0.000 title claims abstract description 16
- 240000009088 Fragaria x ananassa Species 0.000 title claims abstract description 16
- 235000011363 Fragaria x ananassa Nutrition 0.000 title claims abstract description 16
- 240000008866 Ziziphus nummularia Species 0.000 title abstract 2
- 239000003814 drug Substances 0.000 claims abstract description 38
- 240000000759 Lepidium meyenii Species 0.000 claims abstract description 14
- 235000000421 Lepidium meyenii Nutrition 0.000 claims abstract description 14
- 235000012902 lepidium meyenii Nutrition 0.000 claims abstract description 14
- 244000126002 Ziziphus vulgaris Species 0.000 claims description 18
- 241000221377 Auricularia Species 0.000 claims description 13
- 235000006545 Ziziphus mauritiana Nutrition 0.000 claims description 11
- 235000008529 Ziziphus vulgaris Nutrition 0.000 claims description 11
- 241000233866 Fungi Species 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- 235000011034 Rubus glaucus Nutrition 0.000 claims description 5
- 235000009122 Rubus idaeus Nutrition 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 4
- 238000004806 packaging method and process Methods 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 229940126680 traditional chinese medicines Drugs 0.000 claims description 3
- 241001092459 Rubus Species 0.000 claims 3
- 244000235659 Rubus idaeus Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 29
- 210000004369 blood Anatomy 0.000 abstract description 28
- 239000008280 blood Substances 0.000 abstract description 28
- 230000001737 promoting effect Effects 0.000 abstract description 17
- 238000005728 strengthening Methods 0.000 abstract description 17
- 210000000952 spleen Anatomy 0.000 abstract description 14
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract description 10
- 210000004072 lung Anatomy 0.000 abstract description 10
- 230000006870 function Effects 0.000 abstract description 9
- 230000036039 immunity Effects 0.000 abstract description 9
- 210000003734 kidney Anatomy 0.000 abstract description 9
- 230000017531 blood circulation Effects 0.000 abstract description 8
- 230000002708 enhancing effect Effects 0.000 abstract description 8
- 241000721047 Danaus plexippus Species 0.000 abstract description 6
- 230000007812 deficiency Effects 0.000 abstract description 6
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 6
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 5
- 210000002216 heart Anatomy 0.000 abstract description 5
- 230000007774 longterm Effects 0.000 abstract description 5
- 235000016709 nutrition Nutrition 0.000 abstract description 5
- 208000006011 Stroke Diseases 0.000 abstract description 4
- 208000007502 anemia Diseases 0.000 abstract description 4
- 210000004556 brain Anatomy 0.000 abstract description 4
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 4
- 230000035764 nutrition Effects 0.000 abstract description 4
- 239000007787 solid Substances 0.000 abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 4
- 208000030507 AIDS Diseases 0.000 abstract description 3
- 239000000796 flavoring agent Substances 0.000 abstract description 3
- 235000019634 flavors Nutrition 0.000 abstract description 3
- 229910052760 oxygen Inorganic materials 0.000 abstract description 3
- 239000001301 oxygen Substances 0.000 abstract description 3
- 230000001568 sexual effect Effects 0.000 abstract description 3
- 206010008190 Cerebrovascular accident Diseases 0.000 abstract description 2
- 208000001132 Osteoporosis Diseases 0.000 abstract description 2
- 235000010323 ascorbic acid Nutrition 0.000 abstract description 2
- 239000011668 ascorbic acid Substances 0.000 abstract description 2
- 229960005070 ascorbic acid Drugs 0.000 abstract description 2
- 206010003549 asthenia Diseases 0.000 abstract description 2
- 230000003796 beauty Effects 0.000 abstract description 2
- 238000009835 boiling Methods 0.000 abstract description 2
- 230000015271 coagulation Effects 0.000 abstract description 2
- 238000005345 coagulation Methods 0.000 abstract description 2
- 208000029078 coronary artery disease Diseases 0.000 abstract description 2
- 230000003859 lipid peroxidation Effects 0.000 abstract description 2
- -1 oxygen free radical Chemical class 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 238000009098 adjuvant therapy Methods 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 208000033065 inborn errors of immunity Diseases 0.000 abstract 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 abstract 1
- 210000000582 semen Anatomy 0.000 abstract 1
- 235000013311 vegetables Nutrition 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 18
- 241000282414 Homo sapiens Species 0.000 description 15
- 210000002784 stomach Anatomy 0.000 description 15
- 241000700159 Rattus Species 0.000 description 13
- 235000013305 food Nutrition 0.000 description 11
- 244000078534 Vaccinium myrtillus Species 0.000 description 10
- 230000006872 improvement Effects 0.000 description 10
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 8
- 230000036541 health Effects 0.000 description 8
- 230000001965 increasing effect Effects 0.000 description 8
- 235000001014 amino acid Nutrition 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 7
- 210000004204 blood vessel Anatomy 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 210000000988 bone and bone Anatomy 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 240000007651 Rubus glaucus Species 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 235000001465 calcium Nutrition 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 206010061428 decreased appetite Diseases 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 230000001575 pathological effect Effects 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 210000002435 tendon Anatomy 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- 108010082126 Alanine transaminase Proteins 0.000 description 3
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 3
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 3
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 3
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 208000022531 anorexia Diseases 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 230000023555 blood coagulation Effects 0.000 description 3
- 235000021014 blueberries Nutrition 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 235000011649 selenium Nutrition 0.000 description 3
- 229910052711 selenium Inorganic materials 0.000 description 3
- 239000011669 selenium Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 2
- 206010008479 Chest Pain Diseases 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 2
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 2
- 229920002079 Ellagic acid Polymers 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 206010059013 Nocturnal emission Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000010432 diamond Substances 0.000 description 2
- 230000006806 disease prevention Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 235000004132 ellagic acid Nutrition 0.000 description 2
- 229960002852 ellagic acid Drugs 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 206010017758 gastric cancer Diseases 0.000 description 2
- 230000036449 good health Effects 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 235000003642 hunger Nutrition 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 230000036299 sexual function Effects 0.000 description 2
- 201000011549 stomach cancer Diseases 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 239000000052 vinegar Substances 0.000 description 2
- 235000021419 vinegar Nutrition 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 208000026872 Addison Disease Diseases 0.000 description 1
- UCTWMZQNUQWSLP-UHFFFAOYSA-N Adrenaline Natural products CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 206010018286 Gingival pain Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 201000004331 Henoch-Schoenlein purpura Diseases 0.000 description 1
- 206010019617 Henoch-Schonlein purpura Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010021067 Hypopituitarism Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 208000031814 IgA Vasculitis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 1
- 208000000913 Kidney Calculi Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010029148 Nephrolithiasis Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010036297 Postpartum hypopituitarism Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010038084 Rectocele Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 201000009895 Sheehan syndrome Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 208000003441 Transfusion reaction Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000006568 Urinary Bladder Calculi Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 229940102884 adrenalin Drugs 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- OHJMTUPIZMNBFR-UHFFFAOYSA-N biuret Chemical compound NC(=O)NC(N)=O OHJMTUPIZMNBFR-UHFFFAOYSA-N 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000025302 chronic primary adrenal insufficiency Diseases 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 210000000078 claw Anatomy 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000000918 epididymis Anatomy 0.000 description 1
- 201000010063 epididymitis Diseases 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000004383 glucosinolate group Chemical group 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000015446 immunoglobulin a vasculitis Diseases 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 235000017807 phytochemicals Nutrition 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 210000000614 rib Anatomy 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 208000012201 sexual and gender identity disease Diseases 0.000 description 1
- 208000015891 sexual disease Diseases 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000001177 vas deferen Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Toxicology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Biochemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种养生莓耳枣薏瑪粉,以纯天然中药组份:大枣、玛咖、黑莓、薏米、黑菜备制而成。本发明的主要特点是按祖国医学“君、臣、佐、使”原则,充分发挥各组分中药的协同作用,有益气健脾,养心补肾,润肺补脑,滋阴壮阳,降脂降醇,活血抗凝,美容养颜乌发,增强记忆力,防治贫血、冠心病、骨质疏松症,提高免疫力,保护心血管、抗坏血酸,抗脂质过氧化,抗疲劳,抗氧自由基,强身健体,延缓衰老作用。用于亚健康人群,年老体衰,气血不足,久病虚弱,免疫力低下,防治心脑血管病及性中风,对艾滋病有辅助治疗作用;本发明是一种固体冲剂,口感细腻,香味浓郁,营养丰富,携带方便,早晚各一次,沸水冲服。
Description
技术领域:
本发明属于养生保健膳食技术领域;尤其涉及一种具有保健作用、提高机体免疫力的养生保健莓耳枣薏瑪粉及其制备方法。
背景技术:
随着人们生活水平的提高,生活节奏的加快,由于饮食搭配不合理,工作压力加大,休息不足,环境空气污染等因素,处于亚健康状态的人越来越多。我国老龄化速度又在加快,一些老年慢性病卒然增多,于是市场上开始出现品类繁多的养生保健产品,特别是药食两用、具有保健功能的奶粉类、尤其是加入中药成分的豆奶粉等、凸显出保健奶粉“补气健脾,提高免疫力”之功效,是以五脏为本的养生佳品。
但现有技术的这些养生保健膳食产品类,因配方较单一,防病治病、抗衰老不能兼顾,尤其是对提高人的机体免疫力抗氧化作用不高;制造工艺繁琐复杂,生产成本高;解决不了人体快速衰老造成的气血严重匮乏、迫切需要补充的营养成分供应不足,以致慢性病普遍卒发,特别是心、脑血管病症状加重,严重危害人们的生活与健康;生产厂家又使用添加剂来改变“色、味”,其副作用难免对人体造成伤害。
发明内容:
本发明的目的针对上述行业现状存在的问题提供一种具有保健作用、提高机体免疫力、抗氧化、具有药食两用、不含任何化学添加剂、无毒副作用的养生莓耳枣薏瑪粉及其制备方法。
本发明的解决方案是基于祖国传统医学对增加和提高机体免疫力的认识及强化原则,参考古、今药理研究成就,从祖国医学的宝库中,筛选出5种具40大功效:养心补肾,益气健脾,利尿消肿,润肺补脑,滋阴壮阳,强壮筋骨,增强记忆力,通经活络,扩张血管,增强冠状动脉流量,降低胆固醇,宽肠化石,预防心脑血管疾病,活血抗凝,白发转黑,纤体丰胸,有效排除异物,防治贫血,防治冠心病,抗辐射、抗炎,抗溃疡,防治胃、结肠癌,排毒,润肠道、排结石,美容减肥,化解脑血栓,降低高血脂、高血压,提高性能力,缓解女性痛经,防治骨质疏松,活血止血、消肿止痛,保护心血管、抗坏血酸,抗脂质过氧化,延缓衰老的天然中药,按中医理论配伍,使其发挥促进人体内阴阳气血平衡,调节五脏六腑十二经络,对增强人体免疫力,改善微循环具有促进作用。
本发明养生莓耳枣薏瑪粉是由下述中药制备而成:
所述中药按下列重量配比制成:
大枣5-10克,玛咖15-10克,黑莓10-5克,薏米15-10克,黑木耳5-15。
所述养生莓耳枣薏瑪粉由50克中药粉组成。
最优重量配比为:
中药:
大枣5-克,玛咖15克,黑莓10克,薏米15克,黑木耳5克。
上述各组分制成本发明养生莓耳枣薏瑪粉的制备方法是按下述步骤完成的:
大枣5-10克(磨粉),玛咖15-10克(磨粉),黑莓10-5克(磨粉),薏米15-10克(浸泡蒸熟晾干磨粉),黑木耳5-15克(浸泡蒸熟晾干磨粉)。
将上述所制中药粉混合,灭菌处理,质量检查、包装成品。
再次对以上中药各组分加以说明:大枣味甘,性温。入脾、胃经。补脾胃,益气血,安心神,调营卫,和药性。主治脾胃虚弱,气血不足,食少便溏,倦怠乏力,心悸失眠,妇人脏躁,营卫不和等证。含有蛋白质、糖类、有机酸、维生素A、维生素C、多种微量元素钙以及氨基酸等丰富的营养成分。维生素含量非常高,有“天然维生素丸”的美誉。是用于养生保健的安全、有效药物。尤可治疗亚健康体质气血津液不足,补脾和胃及治疗老年人胃虚食少,脾弱便溏作用很好。应用已有2000多年的历史,对治疗过敏性紫癜、贫血、高血压、急慢性肝炎和肝硬化患者的血清转氨酶增高,以及预防输血反应等均有理想效果;含有三萜类化合物及环磷酸腺苷,有较强的抑癌、抗过敏作用。含有抗疲劳作用的物质,能增强人的耐力,还具有减轻毒性物质对肝脏损害的功效。其中的黄酮类化合物,有镇静降血压的作用。现代药理研究表明具增加白血球内的环磷酸腺苷CAMP的作用,具有抗***反应、保肝、增加肌力、镇静、催眠和降压的作用。这些均有利于延年益寿。玛卡味辛、性温,入肺、肾经。温肾壮阳,强筋壮骨,散寒、止痛、调血脉等。主治风湿症、呼吸疾病,抑郁症,贫血症,性功能障碍,阳痿,早泄,更年期综合征等。是一种纯天然食品,营养成份丰富,有“南美人参”之誉。富含高单位营养素,对人体有滋补强身的功用。所具有的独特而且丰富的对人类健康、繁衍、对抗衰老、提供生命动力的植物化学成分和生物活性物质,为玛咖对人类的保健功效和药理作用提供了科学依据。科学家研究发现玛咖含有多种生物碱活性成分、芥子油苷、甾醇、多种氨基酸及对人体健康起特殊生理功能的活性次生代谢物质。黑莓味甘、酸,性温,入肝、肾、膀胱经。起阳治痿,固精摄溺,强肾而无燥热之偏,固精而无疑涩之害,金玉之品。被***粮农组织认定第三代新型特种果,欧美国家赞誉为″生命之果″、″黑钻石″。营养成分每100g含花青素26-27mg/,水杨酸0.5-2.5mg,原花青素0.4g,鞣花酸1.5-2.0mg,总黄酮83mg,硒1.11-2,7mg/kg,SOD 37.5u/ml,维生素C 8.5-10.5mg,氨基酸1000mg,维生素E:3.0mg。富含原花青素、SOD、硒、鞣花酸和类黄酮等高效抗氧化活性物质,二十种氨基酸和微量元素,目前发现含营养成分超过四十种以上,其中原花青素、SOD、氨基酸、以及钙铁锌硒维生素等是我们所熟知的蓝莓的几倍甚至几百倍,因此被欧美国家赞誉为″生命之果″、″黑钻石″。薏苡仁味甘淡、微寒。入脾、胃、肺、大肠经。清热利湿,除风湿,利小便,益肺排脓,健脾胃,强筋骨。主治风湿身痛,湿热脚气,湿热筋急拘挛,湿痹,水肿,肺萎肺痈,咳吐脓血,喉痹痈肿,肠痈热淋。被誉为“世界禾本科植物之王”。可用作粮食吃,且易消化吸收。由于营养丰富,对于久病体虚、病后恢复期患者,老人、产妇、儿童都是比较好的药用食物,可经常服用。不论用于滋补还是用于治病,作用都较为缓和,微寒而不伤胃,益脾而不滋腻。薏苡仁酯,不仅具有滋补作用,而且还是一种抗癌剂,能抑制艾氏腹水癌细胞,可用于胃癌及子***。黑木耳味甘、性平。归胃、大肠经。补气活血,滋润不饥,轻身强志,养血补脑,润肺止咳,抗凝血,降血压,降血脂,活血抗癌,凉血止血,宽肠养容。主治气虚或血热所致腹泻、崩漏、尿血、齿龈疼痛、脱肛、便血等病症。蛋白质的含量是牛奶的六倍,钙、磷、铁纤维素含量也不少,此外,还有甘露聚糖、葡萄糖、木糖等醣类,及卵磷脂、麦角甾醇和维生素C等,具有预防动脉粥样硬化的功效。蛋白质丰富,而且富含多种维生素和矿物质,特别是铁元素含量极高,每100克干木耳含铁达185毫克,是肉类的100倍。是缺铁性贫血患者的极佳食品。还有润肠解毒功能。其中的腺嘌呤核苷有显著的抑制血栓形成的作用,因此,是中老年人的优良保健食品。对胆结石、肾结石、膀胱结石、粪石等内源性异物也有比较显著的化解功能。还含有多种矿物质,能对各种结石产生强烈的化学反应,剥脱、分化、侵蚀结石,使结石缩小,排出。
本发明的第一个重要特点,是组方中含有丰富的氨基酸、维生素及钾、钙、鉄、镁、锌、锡等多种微量元素,这些元素是够成机体代谢酶的辅基。对生物合成起催化作用,促进脑垂体分泌、脂肪代谢、改善微循环,对增强人体内免疫力具有显著功效。
本发明的第二个重要特点,是所配中药组方按照中医“君、臣、佐、使”的配伍原则组成,对人体呈“阴常不足,阳常有余”的虚火体质,依据“阴阳.五行”理论为组方基础,进行合理配伍。黑木耳补气活血,滋润不饥,轻身强志,养血补脑,润肺止咳,抗凝血,降血压,降血脂,活血抗癌,凉血止血,宽肠养容,滋补脏腑、疏通血管、十二经脉为君药。黑莓起阳治痿,固精摄溺辅佐君药为臣药。玛卡温肾壮阳,强筋壮骨,散寒、止痛、调血脉,协同君药缓和君药寒性,增强补益作用为佐药;薏仁清热利湿,除风湿,利小便,益肺排脓,健脾胃,强筋骨与大枣补脾胃,益气血,安心神,调营卫,和药性,寒温并用,性质平和共为使药。全方配伍严谨,计量适宜,不热不寒,营养丰富,性质平和,切合大众化阴虚体质需求,是养生强身的最佳配方,适宜所有亚健康人群男女老幼及孕妇。长期冲服,有利无弊,可返老还童,轻身延年。
本发明的第三个重要特点,降低血粘,软化血管,使血液流行通畅,减少心血管病发生。为卒患心脑血管病患者,快速恢复健康首选的一种固体饮料,携带冲服方便,老少皆宜,效果明显,是防治结合绿色滋补佳品。
本发明的第四个重要特点,有较强的吸附作用,经常食用利于使体内产生的垃圾及时排出体外。对胆结石、肾结石也有较好的化解功能,所含的植物碱具有促进消化道、泌尿道各种腺体分泌的特性,植物碱能协同这些分泌物催化结石,润滑肠道。
本发明具有下述优点:
1、本发明配方合理,选用纯天然“药食两用”中药为原料,不加任何添加剂,制造工艺简单,制做成本低。
2、本发明味甘,性质平和,营养丰富,携带方便,随时冲服,组方所加药物符合药政法和食品卫生等法的规定,《既是药品,又是食品》;并按“君、臣、佐、使”的配伍原则,充分发挥各组分中药的协同作用,集防病、保健于一体,对人体无毒无害。
3、本发明强身健体,延年益寿、具有提高免疫力,促进蛋白质合成,抗氧化,抗疲劳,抗氧自由基,增强体质,减少疾病,防于未然,美容养颜,延缓衰老作用。
4、本发明能预防心血管***的脂肪沉积,防治动脉硬化,保持血管弹性,降血压,降血脂,调节血糖,抗肿瘤,抗氧自由基,防止肝脏、肾脏中***的萎缩,预防胶原变形具有重要意义。对帕金森病,阿尔茨海默氏症,阿狄森氏症,席汉氏综合征,艾滋病(AIDS)有一定的治疗作用。
5、本发明含有丰富的氨基酸,维生素,微量元素,肾上腺素等多种活血抗凝物质。具三抗促防作用,抗凝血、抗血小板聚集、抗血栓形成,促进免疫力,防治动脉硬化。可降低血黏稠度,软化血管,防治脑血管***变窄,使血流动力增强畅通。血液黏稠度高的患者,可以多吃常吃。
6、本发明最突出的一点是连续服用30-90天,自觉症状较以前减轻甚至消失,神消气爽,无倦意,精神饱满,饮食正常,睡眠充足,充满活力,病去人安。
具体实施方法:
实施例1
按下述重量份,称取各原料:
大枣5-10克(磨粉),玛咖15-10克(磨粉),黑莓10-5克(磨粉),薏米15-10克(蒸熟晾干磨粉),黑木耳5-15克(浸泡后蒸熟晾干磨粉),诸药粉混合,包装灭菌,成品入库。
实施例2
按下述重量份,称取各原料:
大枣5克(磨粉),玛咖15克(磨粉),黑莓10克(磨粉),薏米15克(浸泡蒸熟晾干磨粉),黑木耳5克(浸泡蒸熟晾干磨粉),混合,包装灭菌,成品入库。
毒理试验
(一)、试验资料
受试物:一种养生莓耳枣薏瑪粉。
动物及饲养条件:健康(SI)种大鼠,体重120±20g,雌雄各半,分笼群养,常规固体饲料及自来水自由摄取,饲料室温度18℃~25℃。
试验方法和结果:
SD种大鼠160只,雌雄各半,随机分为四组:水对照组(1mI/100g),一种养生莓耳枣薏瑪粉小剂量组(1mI/kg相当于人用量),中剂量组(4mI/kg相当于人用量的四倍),大剂量组(8mI/kg相当于人用量的8倍),每日灌胃一次,连续6个月,每月称重量一次,并观察其食量、外观、行动、分泌物、粪便等,灌胃六个月各组处死14只动物,断头取血,进行血液学、血液生化学检验,对主要脏器进行病理学检查,结果如下:
(二),一般症状的观察
灌入养生莓耳枣薏瑪粉后逐日观察,中、小剂量组动物毛发有光泽,活动自如,外观正常,摄食、粪便等均未见异常,无搓爪、竖尾、抚面、咬牙、全身颤动等兴奋状况,体重逐渐增加,与对照组比较,均无明显差异(P>0.05)。大剂量组动物灌入养生莓耳枣薏瑪粉3个月后无竖毛,活动正常(实验中特别注意观察动物行为),体重增长良好,与对照组比较,差异不显著(P>0.05)。
表1一种养生莓耳枣薏瑪粉长期(6个月)灌入对大鼠体重的影响X±SD单位:g
对照组比较*P>0.05
(三)、血液学检查
于试验第三个月末将大鼠断头处死一半,立即采血做血液学检查,结果表明,各剂量组动物学液学各项指标,均在正常范围内,与对照组比较,无明显差异(P>0.05),如表2示:
表2一种养生莓耳枣薏瑪粉长期(3个月)用药对大白鼠血液学指标的影响X±SD
(四)、血液生化检查
于试验第三个月末,第六个月末分别断头处死相应数量旳大鼠,按常规进行大鼠血清SGPT、SGOT、总蛋白、白蛋白,总胆红素、尿素氮、肌酐检查:
按赖氏法测SGPT,单位(U/L)
按赖氏法测SGOT,单位(U/L)
按双缩脲法测血清总蛋白(G/L
结果如表3示:
与对照组比较P>0.05
以上结果表明,一种养生莓耳枣薏瑪粉灌胃6个月末,大鼠血清SGPT及SGOT无明显升高,与对照组比较,差异不显著(P>0.05)。证明对肝其他项目及肾功能无明显影响。
(五)、病理学检查
于试验3个月末和6个月末及恢复期末断头处死大鼠,迅速解刨肉眼观察体内各脏器,并去除心、肝、脾、肺、肾、卵巢、输精管、子宫、睾丸、附睾、胸腺、肾上腺、肋骨和肠系膜***,用10%甲醛固定,做病理学检查。结果表明,给大鼠灌胃使用养生枣薏粉3个月后,各剂量组动物的各组织细胞形态正常,与对照组无明显差异;6个月后,各剂量组动物的各组织细胞未见特殊病理改变。
以上结果表明,长期服用一种养生莓耳枣薏瑪粉对大鼠主要器官的脏体比无明显影响。
小结
本试验用用一种养生莓耳枣薏瑪粉对大鼠灌胃进行了3个月和6个月的两种性别,三种剂量的长期毒性试验,高剂量组相当于人用量的8倍,与对照组比较,中、小剂量组动物的一般情况良好,血清学各项指标,肝功、肾功均正常,各脏体比与对照组比较无明显差异,各器官组织病理检查未见异常。高剂量组(8mI/kg)大鼠无中毒症状,体重增长正常,病理检查查发现干细胞无明显变化。
抗氧化试食试验
采用自身对照组及组间对照法,选年龄在40-70岁,身体健康状况良好的受试者100例,随机分为试食组和对照组,每组50例。试食组推荐剂量(50mI/天)加食该粉,对照组加食安慰剂。3个月后,其结果表明,试食组与自身及对照组比较MDA下降、SODGH-PX提高明显。因此可以判定,本发明具有抗氧化作用。
亚健康人群食用效果观察
1、观查资料
选择具有亚健康症状者共200例,其中试验组120例,占60%,对照组80例,占40%,200例病例,采用完全随机分组,患者严格控制可变因素和自行联合用药,以保证试验的可比性,观察期间两组均停用其他药及保健品。全部病例符合亚健康状态选择标准,并选择以下症状为观察指标:性功能下降、记忆力减退、失眠、食欲不振、便秘、胸闷。
2、观察方法
2、1.试验组:食用本发明:一种养生莓耳枣薏瑪粉:一次50mI,空腹,早晚各服用一次。30天为一个疗程。
2、2.对照组:食用维维豆奶粉:一次50mI,空腹,早晚各服用一次。30天为1个疗程。
2、3.试验组和对照组均在一个月后观察食用效果。
3、观察结果
3、1.试验组主要症状使用一个月后改善情况,详见表1.
表1试验组主要症状前后改善情况
症状 | 治疗前(+)N | 治疗后(+)N | 改善数N | 改善率(%) |
性功能下降 | 80 | 5 | 75 | 93.75 |
记忆力减退 | 125 | 10 | 115 | 92.00 |
食欲不振 | 150 | 3 | 147 | 98.00 |
失眠 | 165 | 15 | 150 | 90.91 |
便秘 | 170 | 12 | 158 | 92.94 |
胸闷 | 112 | 6 | 109 | 94.78 |
从上表可以看出,试验组性功能下降,记忆力减退,失眠,食欲不振,便秘,胸闷,食用后改善率分别为:93.75%,92.00%,98.00%,90.91%,92.91%,94.78%。
3、2.总体效果,见表2
表2两组总体效果对比表
组别 | 有效率 | 无效率 | 总有效率 |
试验组 | 98.5 | 5.2 | 97.6 |
对照组 | 78.7 | 22.3 | 82.5 |
两组总体疗效的总有效率分别为97.6%和82.5%,两组有显著性差异,P<0.01。表明试验组总体食用效果明显优于对照组。
4、结论
4、1.本发明一种养生莓耳枣薏瑪粉对各种亚健康人群的症状改善作用显著,其改善总有效率为97.6%;
4、2.应用过程中未发现毒副作用和不良反应。
Claims (3)
1.一种养生莓耳枣薏瑪粉,其特征在于它是由下述中药及用量配制而成:所述中药按下列配比制成:大枣5-10克,玛咖15-10克,黑莓10-5克,薏米15-10克,黑木耳5-15克,备置枣薏粉原料的用量为50克中药。
2.根据权利要求1所述的一种养生莓耳枣薏瑪粉,其特征在于制备中药各原料的优选量为:大枣5-克,玛咖15克,黑莓10克,薏米15克,黑木耳5克,制备枣薏粉原料的优选用量为50克中药粉制成。
3.上述权利2各组分制成养生枣薏粉的制备方法是按下述步骤完成的:
大枣5-10克(磨粉),玛咖15-10克(磨粉),黑莓10-5克(磨粉),薏米15-10克(浸泡蒸熟晾干磨粉),黑木耳5-15克(浸泡蒸熟晾干磨粉)。药粉混合,灭菌处理,质量检查、包装成品。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911246400.XA CN111329053A (zh) | 2019-12-06 | 2019-12-06 | 一种养生莓耳枣薏瑪粉 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911246400.XA CN111329053A (zh) | 2019-12-06 | 2019-12-06 | 一种养生莓耳枣薏瑪粉 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111329053A true CN111329053A (zh) | 2020-06-26 |
Family
ID=71173782
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911246400.XA Pending CN111329053A (zh) | 2019-12-06 | 2019-12-06 | 一种养生莓耳枣薏瑪粉 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111329053A (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104957615A (zh) * | 2015-06-30 | 2015-10-07 | 乌鲁木齐益广康源生物科技有限公司 | 一种保健食品配方 |
CN111990508A (zh) * | 2020-09-17 | 2020-11-27 | 傅松涛 | 一种益精茶及其制备方法 |
-
2019
- 2019-12-06 CN CN201911246400.XA patent/CN111329053A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104957615A (zh) * | 2015-06-30 | 2015-10-07 | 乌鲁木齐益广康源生物科技有限公司 | 一种保健食品配方 |
CN111990508A (zh) * | 2020-09-17 | 2020-11-27 | 傅松涛 | 一种益精茶及其制备方法 |
Non-Patent Citations (1)
Title |
---|
玛卡帝国, pages 256, Retrieved from the Internet <URL:https://mp.weixin.qq.com/s/TJqJt49-maV5cgGuG1OVKA> * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103141709B (zh) | 一种鲤鱼饲料及其制备方法 | |
CN101695376B (zh) | 预防糖尿病的保健食品 | |
CN103725469B (zh) | 一种养生干红葡萄酒 | |
CN102763795B (zh) | 一种益母红糖及其制备方法 | |
CN110447902B (zh) | 一种具有减肥功效的组合物 | |
CN101579120A (zh) | 一种具有减肥功能的营养食品及其制备方法 | |
CN108887564A (zh) | 一种硒蛋白杂粮粉配方及其制备方法 | |
CN107373672A (zh) | 一种***女性专用型临床营养配方及其制备方法 | |
CN106937741A (zh) | 一种脱脂亚麻籽粉防癌抗癌健康减肥法及其制备方法 | |
CN106418501A (zh) | 一种具有减肥功能的保健食品 | |
CN103238757B (zh) | 一种含发酵棉粕的蛋鸡配合饲料及其制备方法 | |
CN105249440A (zh) | 一种阿胶糕 | |
CN102511876A (zh) | 山楂红枣浓浆 | |
CN1142785C (zh) | 抗疲劳胶囊 | |
CN108186966A (zh) | 一种预防或改善老年痴呆症的组合物及其应用 | |
CN100506085C (zh) | 一种能够提高产妇免疫力的红糖保健品 | |
CN103181557A (zh) | 具有减肥功能的营养食品及其制备方法 | |
CN106822660A (zh) | 一种治疗心脑血管疾病的中药制剂 | |
CN111329053A (zh) | 一种养生莓耳枣薏瑪粉 | |
CN106173128A (zh) | 一种具有抗疲劳功效的巧克力及其制备方法 | |
CN102138593A (zh) | 荷叶消脂健美茶的配方 | |
CN109258976A (zh) | 一种鸡饲料中的中药添加剂 | |
CN110496212A (zh) | 一种调理酒毒体质的中药组合物及其制备方法 | |
CN112076305A (zh) | 一种治疗人体代谢症候群及杀菌消炎的中药制内服外用原液合剂 | |
CN108967757A (zh) | 一种红枣生姜浓浆生产工艺 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200626 |